Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | N/A | 0 | 19,559 |
| Receivables | 0 | 0 | N/A | 0 | 45,320 |
| Inventories | 0 | 0 | N/A | 0 | 19,839 |
| Other current assets | 0 | 0 | 0 | 0 | 9,492 |
| TOTAL | $0 | $0 | $N/A | $0 | $94,210 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 30,058 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 856,550 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $886,608 |
| Total Assets | $0 | $0 | $N/A | $0 | $978,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | N/A | 0 | 5,160 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 34,970 |
| Accrued Expenses | 0 | 0 | N/A | 0 | 64,700 |
| Other current liabilities | 0 | 0 | N/A | 0 | 12,860 |
| TOTAL | $0 | $0 | $N/A | $0 | $117,833 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | N/A | 0 | 323,661 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 4,160 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $395,371 |
| Total Liabilities | $0 | $0 | $N/A | $0 | $513,295 |
| Shareholders' Equity | |||||
| Other shareholders' equity | 0 | 0 | 0 | 0 | 465,205 |
| TOTAL | $0 | $0 | $N/A | $0 | $465,205 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $978,500 |